GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human clpp in complex with ZG111

Analyse Crystal structure of human clpp in complex with ZG111 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7VP9
Type
protein
Length
2,439 residues
Chains
14
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ATP-dependent clp protease proteolytic subunit, mitochondrial
EC
3.4.21.92
UniProt
Q16740
Ligands
7SR, MG
Pockets
20 · best druggability 0.71

Structure

x-ray diffraction · 11 distinct chains · 45% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, GATP-dependent clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92)protein17046% helix, 21% strandQ16740
CATP-dependent clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92)protein16846% helix, 20% strandQ16740
DATP-dependent clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92)protein17045% helix, 21% strandQ16740
EATP-dependent clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92)protein17146% helix, 21% strandQ16740
FATP-dependent clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92)protein17146% helix, 21% strandQ16740
HATP-dependent clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92)protein18043% helix, 24% strandQ16740
IATP-dependent clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92)protein17844% helix, 22% strandQ16740
JATP-dependent clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92)protein17844% helix, 24% strandQ16740
KATP-dependent clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92)protein17644% helix, 23% strandQ16740
LATP-dependent clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92)protein17944% helix, 25% strandQ16740
M, NATP-dependent clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92)protein17944% helix, 25% strandQ16740

Ligands and binding sites

  • 7SR · (6s,9as)-N-[(4-bromophenyl)methyl]-6-[(2S)-butan-2-yl]-8-(naphthalen-1-ylmethyl)-4,7-bis(oxidanylidene)-3,6, 9,9A-tetrahydro-2H-pyrazino[1,2-a]pyrimidine-1-carboxamide · ligand · 14 copies · chains A, G, B, C, D, E, F, H, N, I, J, K, L, M
  • MG · Magnesium ion · metal · 14 copies · chains A, B, C, D, E, F, G, H, I, J, K, L, M, N

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14810.710.8169empty
22510.690.84267SR
32700.680.83237SR
42520.670.83277SR
52470.670.83287SR

Interfaces

28 interfaces between chains.

  • H–I · 1523 Ų buried · 15 hydrogen bonds · protein-protein
  • I–J · 1445 Ų buried · 12 hydrogen bonds · protein-protein
  • M–N · 1415 Ų buried · 10 hydrogen bonds · protein-protein
  • J–K · 1409 Ų buried · 12 hydrogen bonds · protein-protein
  • A–B · 1382 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 7VP9 · Crystal structure of human ClpP in complex with ZG111 · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.